Predictive role of molecular subtypes in response to neoadjuvant chemotherapy in breast cancer patients
Egyptian Journal of Hospital Medicine [The]. 2018; 71 (2): 2590-2592
em Inglês
| IMEMR
| ID: emr-192503
ABSTRACT
Background:
Breast cancer is increasingly regarded as a heterogeneous disease which can be classified into distinct molecular subtypes with prognosticsignificance:
Buscar no Google
Índice:
IMEMR (Mediterrâneo Oriental)
Assunto principal:
Neoplasias da Mama
/
Estudos Retrospectivos
/
Genes erbB-2
/
Terapia Neoadjuvante
/
Antineoplásicos
Limite:
Humanos
Idioma:
Inglês
Revista:
Egypt. J. Hosp. Med.
Ano de publicação:
2018
Similares
MEDLINE
...
LILACS
LIS